Insmed Inc (NASDAQ: INSM) started the day on Wednesday, with a price increase of 2.14% at $25.81, before settling in for the price of $25.27 at the close. Taking a more long-term approach, INSM posted a 52-week range of $17.41-$32.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 275.45%. Meanwhile, its Annual Earning per share during the time was -4.82%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.57%. This publicly-traded company’s shares outstanding now amounts to $147.98 million, simultaneously with a float of $144.65 million. The organization now has a market capitalization sitting at $3.83 billion. At the time of writing, stock’s 50-day Moving Average stood at $27.19, while the 200-day Moving Average is $25.80.
Insmed Inc (INSM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Insmed Inc’s current insider ownership accounts for 2.59%, in contrast to 101.13% institutional ownership. According to the most recent insider trade that took place on Jan 12 ’24, this organization’s Chief Operating Officer sold 5,251 shares at the rate of 28.63, making the entire transaction reach 150,336 in total value, affecting insider ownership by 148,559. Preceding that transaction, on Jan 12 ’24, Company’s Chief Medical Officer sold 4,667 for 28.63, making the whole transaction’s value amount to 133,616. This particular insider is now the holder of 106,898 in total.
Insmed Inc (INSM) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/31/2023, the organization reported -1.17 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -1.11) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.14 per share during the current fiscal year.
Insmed Inc’s EPS increase for this current 12-month fiscal period is 12.57% and is forecasted to reach -3.96 in the upcoming year.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Let’s observe the current performance indicators for Insmed Inc (INSM). It’s Quick Ratio in the last reported quarter now stands at 3.75. The Stock has managed to achieve an average true range (ATR) of 1.11. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 12.56.
In the same vein, INSM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.35, a figure that is expected to reach -1.23 in the next quarter, and analysts are predicting that it will be -3.96 at the market close of one year from today.
Technical Analysis of Insmed Inc (INSM)
If we take a close look at the recent performances of Insmed Inc (NASDAQ: INSM), its last 5-days Average volume was 3.2 million that shows progress from its year to date volume of 1.78 million. During the previous 9 days, stock’s Stochastic %D was recorded 30.47% While, its Average True Range was 1.18.
Raw Stochastic average of Insmed Inc (INSM) in the period of the previous 100 days is set at 26.96%, which indicates a major fall in contrast to 44.24% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 41.51% that was higher than 39.27% volatility it exhibited in the past 100-days period.
